What's Happening?
The Tampa General Hospital (TGH) Cancer Institute, in collaboration with the USF Health Morsani College of Medicine and the Global Virus Network, hosted the 'Microbes, Genes & Cancer' Symposium in Tampa. This event brought together international leaders
in oncology, virology, and immunology to discuss the intersection of microbes, genetics, and immune pathways in cancer development and treatment. The symposium also marked the 50th anniversary of the discovery of Interleukin-2 (IL-2), a pivotal breakthrough in cancer immunotherapy. The event highlighted Tampa General's growing influence in cancer research and its ability to convene leading scientific minds to foster collaboration and innovation.
Why It's Important?
The symposium underscores the critical role of interdisciplinary collaboration in advancing cancer research and treatment. By bringing together experts from various fields, the event facilitated discussions on emerging questions in cancer biology, potentially leading to new strategies for cancer prevention, diagnosis, and treatment. The focus on IL-2's anniversary highlights the ongoing impact of past scientific breakthroughs on current and future cancer therapies, such as CAR T cell therapy. This gathering not only enhances Tampa General's reputation as a leader in cancer research but also contributes to the global effort to improve cancer patient outcomes.
